The Alabama Department of Public Health is working with other health agencies to investigate an injectable anti-inflammatory drug prepared by a compounding manufacturer in Tennessee.
Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states.
The investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of methylprednisolone acetate (MPA). It’s the same drug that was linked to last year’s deadly outbreak of fungal meningitis.
The investigation is in an early stage and is rapidly evolving, according to Dr. Mary McIntyre of the ADPH.
Was this article valuable?
Here are more articles you may enjoy.
UBS Top Executives to Appear at Senate Hearing on Credit Suisse Nazi Accounts 
Navigators Can’t Parse ‘Additional Insured’ Policy Wording in Georgia Explosion Case 
China Bans Hidden Car Door Handles in World-First Safety Policy 
Hackers Hit Sensitive Targets in 37 Nations in Spying Plot 
Want to stay up to date?
Get the latest insurance news
sent straight to your inbox.